A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer R Hitt, JJ Grau, A López-Pousa, A Berrocal, C García-Girón, A Irigoyen, ... Annals of Oncology 25 (1), 216-225, 2014 | 359 | 2014 |
Taxane-cisplatin-fluorouracil as induction chemotherapy in locally advanced head and neck cancers: an individual patient data meta-analysis of the meta-analysis of chemotherapy … P Blanchard, J Bourhis, B Lacas, MR Posner, JB Vermorken, ... Journal of clinical oncology 31 (23), 2854-2860, 2013 | 332 | 2013 |
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group B Lacas, A Carmel, C Landais, SJ Wong, L Licitra, JS Tobias, B Burtness, ... Radiotherapy and Oncology 156, 281-293, 2021 | 227 | 2021 |
Phase II study of the combination of cetuximab and weekly paclitaxel in the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of head … R Hitt, A Irigoyen, H Cortes-Funes, JJ Grau, JA García-Sáenz, ... Annals of Oncology 23 (4), 1016-1022, 2012 | 226 | 2012 |
Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: A high proportion of mutations unique to Spain and evidence of founder effects O Díez, A Osorio, M Durán, JI Martinez‐Ferrandis, M Hoya, R Salazar, ... Human mutation 22 (4), 301-312, 2003 | 222 | 2003 |
Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial SE Kasner, B Swaminathan, P Lavados, M Sharma, K Muir, R Veltkamp, ... The Lancet Neurology 17 (12), 1053-1060, 2018 | 183 | 2018 |
6q deletion in Waldenström macroglobulinemia is associated with features of adverse prognosis EM Ocio, RFJ Schop, B Gonzalez, SA Van Wier, JM Hernandez‐Rivas, ... British journal of haematology 136 (1), 80-86, 2007 | 137 | 2007 |
Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell … J Guigay, A Aupérin, J Fayette, E Saada-Bouzid, C Lafond, M Taberna, ... The Lancet Oncology 22 (4), 463-475, 2021 | 128 | 2021 |
Reversible posterior leukoencephalopathy syndrome induced by sunitinib G Martín, L Bellido, JJ Cruz Journal of clinical oncology: official journal of the American Society of …, 2007 | 125 | 2007 |
Liquid biopsy as novel tool in precision medicine: Origins, properties, identification and clinical perspective of cancer’s biomarkers D Fernández-Lázaro, JL García Hernández, AC García, ... Diagnostics 10 (4), 215, 2020 | 113 | 2020 |
Mass mortality of tropical marine communities in Morrocoy, Venezuela EN Laboy-Nieves, E Klein, JE Conde, F Losada, JJ Cruz, D Bone Bulletin of Marine Science 68 (2), 163-179, 2001 | 106 | 2001 |
Final results of a randomized phase III trial comparing induction chemotherapy with cisplatin/5-FU or docetaxel/cisplatin/5-FU follow by chemoradiotherapy (CRT) versus CRT … R Hitt, JJ Grau, A Lopez-Pousa, A Berrocal, C Garcia Giron, A Irigoyen, ... Journal of Clinical Oncology 27 (15_suppl), 6009-6009, 2009 | 103 | 2009 |
Contributions of mean and shape of blood pressure distribution to worldwide trends and variations in raised blood pressure: a pooled analysis of 1018 population-based … International journal of epidemiology 47 (3), 872-883i, 2018 | 92 | 2018 |
Evaluation of multiparameter flow cytometry for the detection of breast cancer tumor cells in blood samples I Cruz, J Ciudad, JJ Cruz, M Ramos, A Gómez-Alonso, JC Adansa, ... American journal of clinical pathology 123 (1), 66-74, 2005 | 92 | 2005 |
Multidisciplinary consensus on the therapeutic recommendations for iatrogenic hyperprolactinemia secondary to antipsychotics ÁL Montejo, C Arango, M Bernardo, JL Carrasco, B Crespo-Facorro, ... Frontiers in Neuroendocrinology 45, 25-34, 2017 | 90 | 2017 |
E-cadherin, laminin and collagen IV expression in the evolution from dysplasia to oral squamous cell carcinoma AS García, MMA Hernández, EF Sánchez, RJ Gonzalez, ... Medicina oral, patología oral y cirugía bucal. Ed. inglesa 11 (2), 1, 2006 | 89 | 2006 |
Neuregulin expression modulates clinical response to trastuzumab in patients with metastatic breast cancer E de Alava, A Ocana, M Abad, JC Montero, A Esparís-Ogando, ... Journal of Clinical Oncology 25 (19), 2656-2663, 2007 | 84 | 2007 |
Emergence of resistance to daptomycin in a cohort of patients with methicillin-resistant Staphylococcus aureus persistent bacteraemia treated with daptomycin O Gasch, M Camoez, MA Domínguez, B Padilla, V Pintado, B Almirante, ... Journal of Antimicrobial Chemotherapy 69 (2), 568-571, 2014 | 83 | 2014 |
The current and future role of the medical oncologist in the professional care for cancer patients: a position paper by the European Society for Medical Oncology (ESMO) RA Popescu, R Schäfer, R Califano, R Eckert, R Coleman, JY Douillard, ... Annals of oncology 25 (1), 9-15, 2014 | 79 | 2014 |
Evidence for non-communicable diseases: analysis of Cochrane reviews and randomised trials by World Bank classification C Heneghan, C Blacklock, R Perera, R Davis, A Banerjee, P Gill, S Liew, ... BMJ open 3 (7), e003298, 2013 | 74 | 2013 |